文献速递认知障碍与谵妄多重用药老年综合评估

居家医疗中痴呆老年人抗精神病药使用:患病率、预测因素与结局

Antipsychotic use among older patients with dementia receiving home health care services: Prevalence, predictors, and outcomes.
PubMed 文献 · J Am Geriatr Soc · 2023-09-06

本研究为2019年纽约某居家医疗(HHC)机构≥65岁成人(N=6684)的二次分析,比较合并与不合并阿尔茨海默病及相关痴呆(ADRD)者抗精神病药使用情况。合并ADRD者用药时点患病率为17.2%,无ADRD者为6.6%;合并ADRD者用药与出院时ADL改善更少相关(β=-0.70,p<0.001)。

要点

  • 合并ADRD的HHC患者抗精神病药时点患病率为17.2%,高于无ADRD者的6.6%。
  • 合并ADRD者中,行为心理症状是用药的强预测因素(OR=5.26,p=0.002)。
  • 合并ADRD者使用抗精神病药与HHC出院时ADL改善更少相关(β=-0.70,p<0.001)。

核心结论

  • HHC中合并ADRD的老年患者更可能使用抗精神病药,且用药者功能结局更差。
  • 应系统审查抗精神病药,在存在禁忌或不必要时进行减停。

研究设计与样本

  • 研究为对2019年纽约某HHC机构接受照护的≥65岁成人(N=6684)的二次分析。
  • 数据来自Outcome and Assessment Information Set、Medicare HHC索赔及电子HHC记录中的家庭药物审查结果,覆盖60天HHC episode。
  • ADRD依据诊断代码识别;功能结局为HHC入院至出院复合ADL评分变化(5833例测量),正分示改善、负分示下降。
  • 采用logistic回归分析预测因素,线性回归分析用药与结局的关联。

主要发现

  • 抗精神病药时点患病率在合并ADRD者为17.2%,无ADRD者为6.6%。
  • 合并ADRD者中,用药预测因素包括ADL受限更多(OR=1.30,p=0.01)、用药数量更多(OR=1.04,p=0.02)、存在行为心理症状(OR=5.26,p=0.002)及独居(OR=0.52,p=0.06)。
  • 合并ADRD者中,抗精神病药使用与HHC出院时ADL改善更少相关(β=-0.70,p<0.001)。

关键数值与推荐

  • 合并ADRD者抗精神病药时点患病率为17.2%,无ADRD者为6.6%。
  • 合并ADRD者中ADL受限更多的OR=1.30(p=0.01),用药数量更多的OR=1.04(p=0.02)。
  • 合并ADRD者中行为心理症状的OR=5.26(p=0.002),独居的OR=0.52(p=0.06)。
  • 合并ADRD者抗精神病药使用与ADL改善更少的β=-0.70(p<0.001)。

临床怎么用

  • 对HHC中合并ADRD的老年患者应系统审查抗精神病药,存在禁忌或不必要时减停。
  • 需改善HHC患者获得非药物干预的机会,并为照护者提供行为管理症状的教育。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antipsychotic use is a safety concern among older patients in home health care (HHC), particularly for those with Alzheimer's disease and related dementias (ADRD). The objective of this study was to examine the prevalence and predictors of antipsychotic use among older adults with and without ADRD who received HHC, and the association of antipsychotic use with outcomes among patients living with ADRD. METHODS: In this secondary analysis of adults ≥65 years receiving care from an HHC agency in New York in 2019 (N = 6684), we used data from the Outcome and Assessment Information Set, Medicare HHC claims, and home medication review results in the electronic HHC records during a 60-day HHC episode. ADRD was identified by diagnostic codes. Functional outcome was the change in the composite activities of daily living (ADL) score from HHC admission to HHC discharge (measured in 5833 patients), where a positive score means improvement and a negative score means decline. Data were analyzed using logistic (predictors) and linear regression (association with outcome) analyses. RESULTS: The point prevalence of antipsychotic use was 17.2% and 6.6% among patients with and without ADRD, respectively. Among patients living with ADRD, predictors of antipsychotic use included having greater ADL limitations (odds ratio [OR] = 1.30, p = 0.01), taking more medications (OR = 1.04, p = 0.02), having behavioral and psychological symptoms (OR = 5.26, p = 0.002), and living alone (OR = 0.52, p = 0.06). Among patients living with ADRD, antipsychotic use was associated with having less ADL improvement at HHC discharge (β = -0.70, p < 0.001). CONCLUSIONS: HHC patients living with ADRD were more likely to use antipsychotics and to experience worse functional outcomes when using antipsychotics. Antipsychotics should be systematically reviewed and, if contraindicated or unnecessary, deprescribed. Efforts are needed to improve HHC patients' access to nonpharmacological interventions and to provide education for caregivers regarding behavioral approaches to manage symptoms in ADRD.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Wang J, Shen JY, Conwell Y, et al. Antipsychotic use among older patients with dementia receiving home health care services: Prevalence, predictors, and outcomes. J Am Geriatr Soc. 2023. PMID: 37671461. doi:10.1111/jgs.18555

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。